Does CLONAZEPAM Cause Affect lability? 74 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Affect lability have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.2% of all adverse event reports for CLONAZEPAM.
74
Reports of Affect lability with CLONAZEPAM
0.2%
of all CLONAZEPAM reports
1
Deaths
37
Hospitalizations
How Dangerous Is Affect lability From CLONAZEPAM?
Of the 74 reports, 1 (1.4%) resulted in death, 37 (50.0%) required hospitalization, and 3 (4.1%) were considered life-threatening.
Is Affect lability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does CLONAZEPAM Cause?
Drug ineffective (5,088)
Toxicity to various agents (4,028)
Completed suicide (3,320)
Drug abuse (3,287)
Off label use (2,590)
Anxiety (2,376)
Somnolence (2,260)
Dyspnoea (1,987)
Depression (1,838)
Insomnia (1,836)
What Other Drugs Cause Affect lability?
DULOXETINE (2,510)
METFORMIN (291)
AMLODIPINE (274)
METHOTREXATE (266)
ATORVASTATIN (259)
IRBESARTAN (257)
LEVOTHYROXINE (251)
SITAGLIPTIN (244)
ESOMEPRAZOLE (234)
ASPIRIN (224)
Which CLONAZEPAM Alternatives Have Lower Affect lability Risk?
CLONAZEPAM vs CLONIDINE
CLONAZEPAM vs CLOPIDOGREL
CLONAZEPAM vs CLOPIDOGREL BESILATE
CLONAZEPAM vs CLOPIDOGREL BISULFATE
CLONAZEPAM vs CLORAZEPATE